Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2025-12-24 @ 6:58 PM
NCT ID:
NCT05635357
Eligibility Criteria:
Please see https://docs.google.com/spreadsheets/d/1GrnVsPCockqqdfxC9LWd6ndbzS2wpJVvTbCOAhn4DLM/edit?usp=sharing or Appendix A (https://drive.google.com/drive/folders/1I8FVmpPzC5wQN9DFIv1Rbwh1N0SLEv0B?usp=sharing) for full code and algorithm definitions.
Medicare timeframe: 2008 to 2018 (end of data availability)
Inclusion Criteria:
* 1\. Aged \>/= 65 years on the index date
* 2\. Enrollment in Medicare Part A, B, and D with no HMO coverage for 365 days prior to and including cohort entry date
* 3\. At least two claims with breast cancer diagnosis measured 365 days prior to drug initiation
Exclusion Criteria:
* 1\. Prior history of dementia measured anytime prior to cohort entry date
* 2\. Prior history of nursing home admission anytime prior to cohort entry date
* 3\. Prior history of Anastrozole or Exemestane/Letrozole use anytime prior to cohort entry date
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT05635357
Study Brief:
Protocol Section:
NCT05635357